AbbVie Stock Hits Day High with Strong Intraday Performance, Up 3.29%

AbbVie, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 3.29% as of February 27, 2026. The stock reached an intraday high of USD 232.27, reflecting its strong performance relative to the broader market. In comparison to the S&P 500, which experienced a decline of 0.43% on the same day, AbbVie’s performance stands out. Over the past week, the stock has increased by 3.23%, while the S&P 500 fell by 0.44%. Looking at a broader timeframe, AbbVie has achieved a 3.64% gain over the past month, contrasting with the S&P 500's 1.43% decline. Despite a 1-year performance of 13.2%, which lags behind the S&P 500's 17.36%, AbbVie has demonstrated resilience with a notable 50.43% increase over the past three years and an impressive 115.41% rise over the last five years. The company maintains a market capitalization of approximately USD 404.96 billion, with a P/E ratio of 28.00 and a dividend yield of 2.90%.